XML 38 R28.htm IDEA: XBRL DOCUMENT v3.19.2
Other disclosures - Credit Risk
6 Months Ended
Jun. 30, 2019
Other disclosures - Credit Risk  
Other disclosures - Credit Risk

Loans and advances at amortised cost by product

The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.

Stage 2
As at 30.06.19Stage 1Not past due<=30 days past due>30 days past dueTotalStage 3Total1
Gross exposure£m£m£m£m£m£m£m
Home loans11,26261460927661,18313,211
Credit cards, unsecured loans and other retail lending31,7534,2273052904,8222,05738,632
Corporate loans 86,1267,6955951,0009,2901,13696,552
Total129,14112,5369601,38214,8784,376148,395
Impairment allowance
Home loans2826111047318393
Credit cards, unsecured loans and other retail lending3495631051438111,4232,583
Corporate loans 122225186249384755
Total4998141341591,1072,1253,731
Net exposure
Home loans11,234588498271986512,818
Credit cards, unsecured loans and other retail lending31,4043,6642001474,01163436,049
Corporate loans 86,0047,4705779949,04175295,797
Total128,64211,7228261,22313,7712,251144,664
Coverage ratio%%%%%%%
Home loans0.24.218.310.96.126.93.0
Credit cards, unsecured loans and other retail lending1.113.334.449.316.869.26.7
Corporate loans 0.12.93.00.62.733.80.8
Total0.46.514.011.57.448.62.5
As at 31.12.18
Gross exposure£m£m£m£m£m£m£m
Home loans11,486663501478601,19413,540
Credit cards, unsecured loans and other retail lending29,5484,3813052404,9262,07836,552
Corporate loans 81,5557,4803154438,23891790,710
Total122,58912,52467083014,0244,189140,802
Impairment allowance
Home loans26299947307380
Credit cards, unsecured loans and other retail lending3566941181609721,4332,761
Corporate loans 1072141111236359702
Total4899371381801,2552,0993,843
Net exposure
Home loans11,4606344113881388713,160
Credit cards, unsecured loans and other retail lending29,1923,687187803,95464533,791
Corporate loans 81,4487,2663044328,00255890,008
Total122,10011,58753265012,7692,090136,959
Coverage ratio%%%%%%%
Home loans0.24.418.06.15.525.72.8
Credit cards, unsecured loans and other retail lending1.215.838.766.719.769.07.6
Corporate loans 0.12.93.52.52.939.10.8
Total0.47.520.621.78.950.12.7

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income, accrued income and sundry debtors. These have a total gross exposure of £159.9bn (December 2018: £120.1bn) and impairment allowance of £21m (December 2018: £11m). This comprises £13m (December 2018: £9m) Expected Credit Loss (ECL) on £159.4bn (December 2018: £119.6bn) Stage 1 assets, £3m (December 2018: £2m) on £0.5bn (December 2018: £0.5bn) Stage 2 fair value through other comprehensive income assets and £5m (December 2018: £nil) on £5m (December 2018: £nil) Stage 3 other assets.

Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees

The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. Explanation of the terms: 12-month ECL, lifetime ECL and credit-impaired are included in the Barclays Bank PLC Annual Report 2018 on page 173. Barclays Bank Group does not hold any material purchased or originated credit-impaired assets as at period end.

Stage 1Stage 2Stage 3Total
Gross exposure for loans and advances at amortised cost£m£m£m£m
As at 1 January 2019122,58914,0244,189140,802
Transfers from Stage 1(4,661)4,348313-
Transfers from Stage 23,540(4,255)715-
Transfers from Stage 33698(134)-
Business activity in the year32,3369842533,345
Net drawdowns and repayments(2,880)1,482331(1,067)
Final repayments(21,819)(1,803)(415)(24,037)
Disposals--(21)(21)
Write-offs1--(627)(627)
As at 30 June 2019129,14114,8784,376148,395
Stage 1Stage 2Stage 3Total
Impairment allowance on loans and advances at amortised cost£m£m£m£m
As at 1 January 20194891,2552,0993,843
Transfers from Stage 1(58)517-
Transfers from Stage 2246(456)210-
Transfers from Stage 317(8)-
Business activity in the year95395139
Net re-measurement and movement due to exposure and risk parameter changes(243)251513521
Final repayments(31)(40)(53)(124)
Disposals--(21)(21)
Write-offs1--(627)(627)
As at 30 June 201924991,1072,1253,731
Reconciliation of ECL movement to impairment charge/(release) for the period£m
ECL movement excluding assets derecognised due to disposals and write-offs536
Post write-off recoveries1(47)
Exchange and other adjustments(7)
Impairment charge on loan commitments and financial guarantees22
Impairment charge on other financial assets26
Income statement charge/(release) for the period510

1 In H119, gross write-offs amounted to £627m (H118: £788m) and post write-off recoveries amounted to £47m (H118: £43m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £580m (H118: £745m).

2 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income, accrued income and sundry debtors. These have a total gross exposure of £159.9bn (December 2018: £120.1bn) and impairment allowance of £21m (December 2018: £11m). This comprises £13m ECL (December 2018: £9m) on £159.4bn stage 1 assets (December 2018: £119.6bn) and £3m (December 2018: £2m) on £0.5bn stage 2 fair value through other comprehensive income assets (December 2018: £0.5bn) and £5m (December 2018: £nil) on £5m Stage 3 other assets (December 2018: £nil).

Stage 1Stage 2Stage 3Total
Gross exposure for loan commitments and financial guarantees£m£m£m£m
As at 1 January 2019248,59016,444421265,455
Net transfers between stages(506)142364-
Business activity in the year44,0431,538945,590
Net drawdowns and repayments(2,348)997(282)(1,633)
Final repayments(27,183)(4,092)(234)(31,509)
As at 30 June 2019262,59615,029278277,903
Stage 1Stage 2Stage 3Total
Impairment allowance on loan commitments and financial guarantees£m£m£m£m
As at 1 January 20199110422217
Net transfers between stages8(6)(2)-
Business activity in the year2625758
Net re-measurement and movement due to exposure and risk parameter changes(17)1463
Final repayments(15)(26)(1)(42)
As at 30 June 20199311132236